Observational Study
Copyright ©The Author(s) 2016.
World J Obstet Gynecol. May 10, 2016; 5(2): 187-196
Published online May 10, 2016. doi: 10.5317/wjog.v5.i2.187
Table 1 Characteristics of ovarian cancer patients who received any initial surgical procedure by physician specialty (n = 6714)
CharacteristicSurgeon specialty1
GONon-GO
OBGYNGeneral surgeonOther2
No. of patients22543088914419
Mean age at diagnosis (stddev)74.6 (5.9)74.8 (6.1)77.0 (6.8)75.5 (6.2)
Race n (%)
White1995 (88.5)2844 (92.1)827 (90.5)379 (90.5)
African American121 (5.4)104 (3.4)49 (5.4)26 (6.2)
Hispanic35 (1.6)31 (1.0)33
Asian53 (2.4)66 (2.1)33
Other447 (2.1)37 (1.2)33
Marital status
Married1052 (46.7)1424 (46.1)327 (35.8)170 (40.6)
Single159 (7.1)221 (7.2)53 (5.8)31 (7.4)
Divorced148 (6.6)166 (5.4)58 (6.3)29 (6.9)
Widowed799 (35.4)1168 (37.8)458 (50.1)176 (42.0)
Separated/unknown96 (4.2)109 (3.5)33
Charlson-Klabunde comorbidity score
01521 (67.5)2133 (69.1)605 (66.2)266 (63.5)
1498 (22.1)644 (20.9)188 (20.6)93 (22.2)
2175 (7.8)189 (6.1)78 (8.5)38 (9.1)
345 (2.0)80 (2.6)29 (3.2)3
4 or more342 (1.4)33
FIGO treatment stage
IA/IB200 (8.9)383 (12.4)66 (7.2)43 (10.3)
IC/II276 (12.2)516 (16.7)90 (9.8)40 (9.5)
IIIA/IIIB119 (5.3)179 (5.8)59 (6.5)3
IIIC/IV1580 (70.1)1898 (61.5)660 (72.2)308 (73.5)
Unstaged/NOS79 (3.5)112 (3.7)39 (4.2)3
Histology
Serous1460 (64.8)1897 (61.4)554 (60.6)254 (60.6)
Endometrioid238 (10.6)381 (12.3)73 (8.0)46 (11.0)
Mucinous129 (5.7)235 (7.6)79 (8.6)25 (6.0)
Clear cell84 (3.7)127 (4.1)33
Adenocarcinoma275 (12.2)344 (11.1)175 (19.1)66 (15.8)
Other568 (3.1)104 (3.3)20 (2.2)3